Pays: Suisse
Langue: français
Source: Swissmedic (Swiss Agency for Therapeutic Products)
argentum metallicum (HAB) D29 aquos. (HAB 8b), atropa belladonna ex herba rec. ferm 33a D14 (HAB 33a), echinacea pallida e planta tota rec. ferm 33c D2 (HAB 33c), quarz (HAB) D19 aquos., rosae aetheroleum D7 (HAB 5a)
WALA Schweiz AG
argentum metallicum (HAB) D29 aquos. (HAB 8b), atropa belladonna ex herba rec. ferm 33a D14 (HAB 33a), echinacea pallida e planta tota rec. ferm 33c D2 (HAB 33c), quarz (HAB) D19 aquos., rosae aetheroleum D7 (HAB 5a)
Collyre
argentum metallicum (HAB) D29 aquos. (HAB 8b) 100 mg, atropa belladonna ex herba rec. ferm 33a D14 (HAB 33a) 100 mg, echinacea pallida e planta tota rec. ferm 33c D2 (HAB 33c) 100 mg, quarz (HAB) D19 aquos. 100 mg, rosae aetheroleum D7 (HAB 5a) 100 mg, natrii chloridum, natrii hydrogenocarbonas, aqua ad iniectabile, ad solutionem pro 1 ml, corresp. 33 guttae.
D
Médicaments Anthroposophiques
Zulassung mit reduziertem Dossier ohne Indikation nach Art. 25 Abs. 1 KPAV (SR 812.212.24)
zugelassen
2013-09-25